On the contrary, measuring t-Tau and p-tau with Lumipulse is validated for clinical practice in the search of cognitive impairment: t-Tau higher 410 pg/mL and p-Tau higher than 60 pg/mL are considered abnormal. Here, MAPT is linked to Cognitive impairment.